Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
3,415
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
3,415
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2020-12-04 13:32 | Report Abuse
Shootup Is so naive and dumb. He thinks theres no operator suppressing the price. Hence he must be the culprit... lol
Stock
2020-12-04 13:23 | Report Abuse
@shootup i will report you as well...
Stock
2020-12-04 13:22 | Report Abuse
@Shootup Becareful what you accuse me of. I will personally come and find you and beat you up. You must be the operator pushing down the price. Since you are denying there is one in the first place.
Stock
2020-12-04 12:41 | Report Abuse
@Citadel12 You must be the operator here pushing down the price. I would need to report you kekeke
Stock
2020-12-04 12:34 | Report Abuse
Is there anyway to report this to bursa? Everyday the operator controlling the price...
Stock
2020-12-04 02:59 | Report Abuse
American study finds signs of coronavirus in US before China outbreak
• US CDC says blood samples taken in nine states before cases were reported in Wuhan tested positive for antibodies for the pathogen
• Results indicate that infections might have happened in the western US earlier than previously thought, scientists say
The US CDC has reported research that indicates infections might have occurred in the western United States earlier than previously thought.
The US has added to research from Italy and France that indicates the coronavirus might have been circulating among people in a number of countries before it was identified in China and erupted into a pandemic.
Scientists from the US Centres for Disease Control and Prevention (CDC) said on Monday that tests of blood samples taken in the United States from December 13 last year revealed evidence of antibodies for the Covid-19 virus, known as Sars-Cov-2.
The samples were taken more than two weeks before the December 31 official confirmation of the outbreak in the central Chinese city of Wuhan and as much as a month earlier than the first confirmed case of Covid-19 in the US on January 19, according to the CDC report.
Antibodies are generated by the human immune system to identify and attack pathogens in the body and are specific to each type of virus, bacteria or parasite.
“The presence of these serum antibodies indicate that isolated Sars-CoV-2 infections may have occurred in the western portion of the United States earlier than previously recognised,” CDC scientists wrote in the study, which was published in the peer-reviewed journal Clinical Infectious Diseases.
https://www.scmp.com/news/china/science/article/3112160/american-study-finds-signs-coronavirus-us-china-outbreak
Stock
2020-12-04 02:59 | Report Abuse
American study finds signs of coronavirus in US before China outbreak
• US CDC says blood samples taken in nine states before cases were reported in Wuhan tested positive for antibodies for the pathogen
• Results indicate that infections might have happened in the western US earlier than previously thought, scientists say
The US CDC has reported research that indicates infections might have occurred in the western United States earlier than previously thought.
The US has added to research from Italy and France that indicates the coronavirus might have been circulating among people in a number of countries before it was identified in China and erupted into a pandemic.
Scientists from the US Centres for Disease Control and Prevention (CDC) said on Monday that tests of blood samples taken in the United States from December 13 last year revealed evidence of antibodies for the Covid-19 virus, known as Sars-Cov-2.
The samples were taken more than two weeks before the December 31 official confirmation of the outbreak in the central Chinese city of Wuhan and as much as a month earlier than the first confirmed case of Covid-19 in the US on January 19, according to the CDC report.
Antibodies are generated by the human immune system to identify and attack pathogens in the body and are specific to each type of virus, bacteria or parasite.
“The presence of these serum antibodies indicate that isolated Sars-CoV-2 infections may have occurred in the western portion of the United States earlier than previously recognised,” CDC scientists wrote in the study, which was published in the peer-reviewed journal Clinical Infectious Diseases.
https://www.scmp.com/news/china/science/article/3112160/american-study-finds-signs-coronavirus-us-china-outbreak
Stock
2020-12-04 02:53 | Report Abuse
Coronavirus epidemic was spreading in US last Christmas, long before it was identified in China, new study finds
https://thehill.com/changing-america/well-being/medical-advances/528123-coronavirus-epidemic-was-spreading-in-us-last
Stock
2020-12-04 02:52 | Report Abuse
A new study found coronavirus may have been in the US in December. That doesn't mean you'll ever know if you had it then
https://edition.cnn.com/2020/12/01/health/covid-antibody-blood-december-study/index.html
Stock
2020-12-04 02:52 | Report Abuse
A new study found coronavirus may have been in the US in December. That doesn't mean you'll ever know if you had it then
https://edition.cnn.com/2020/12/01/health/covid-antibody-blood-december-study/index.html
Stock
2020-12-04 02:51 | Report Abuse
Coronavirus epidemic was spreading in US last Christmas, long before it was identified in China, new study finds
https://thehill.com/changing-america/well-being/medical-advances/528123-coronavirus-epidemic-was-spreading-in-us-last
Stock
2020-12-04 02:10 | Report Abuse
“And for its part, the Ministry of Finance and Public Credit is making all the budgetary and financial plans to have budget sufficiency and purchase the vaccines from Pfizer, CanSino and AstraZeneca,” he said.
https://www.explica.co/covid-19-mexico-closes-contract-with-pfizer-and-advances-its-vaccination-plan/
Stock
2020-12-04 02:08 | Report Abuse
Chinese vaccines progress steadily as more nations mull mass inoculation
Chinese vaccines progress steadily for approval
East China's Jiangsu Province announced on Thursday it would start vaccine procurement from leading producers, including Sinopharm and Sinovac. It became the latest province to secure its doses after Zhejiang and Sichuan provinces.
China is very likely to introduce its first officially approved vaccine for mass use in December. It will either be the inactivated vaccine from Sinovac or state-owned Sinopharm, a Beijing-based immunological professor who asked not to be named told the Global Times.
https://www.globaltimes.cn/content/1208924.shtml
Stock
2020-12-04 02:08 | Report Abuse
Chinese vaccines progress steadily as more nations mull mass inoculation
Chinese vaccines progress steadily for approval
East China's Jiangsu Province announced on Thursday it would start vaccine procurement from leading producers, including Sinopharm and Sinovac. It became the latest province to secure its doses after Zhejiang and Sichuan provinces.
China is very likely to introduce its first officially approved vaccine for mass use in December. It will either be the inactivated vaccine from Sinovac or state-owned Sinopharm, a Beijing-based immunological professor who asked not to be named told the Global Times.
https://www.globaltimes.cn/content/1208924.shtml
Stock
Stock
2020-12-04 00:16 | Report Abuse
China Ready To Dispatch Millions Of COVID Vaccine Doses To The World
Vaccine Ready To Dispatch
The climate control rooms, covering an area of 350 square meters (3,767 square meters), will soon be filled with rows and lines of Chinese-made Covid-19 vaccine – after obtaining approval from the country’s drug regulators. From there, they will be loaded into air-conditioned parts of cargo jets and fly to continents around the world.
The climate-controlled chambers at Shenzhen's international airport will soon be filled with Chinese-made coronavirus vaccines.
In the coming months, China will send hundreds of millions of doses of coronavirus vaccines to countries that have undergone end-stage testing. Chinese leaders have also promised a growing list of developing countries to have access to effective vaccines.
This global campaign gives China a chance to fix its image, which has been damaged by first-hand treatment of the coronavirus – rather than blaming the underlying spread of the undiagnosed virus for helping to eradicate the epidemic.
https://cloutnews.com/china-ready-to-dispatch-millions-of-covid-vaccine-doses-to-the-world/
Stock
2020-12-04 00:15 | Report Abuse
China Ready To Dispatch Millions Of COVID Vaccine Doses To The World
Vaccine Ready To Dispatch
The climate control rooms, covering an area of 350 square meters (3,767 square meters), will soon be filled with rows and lines of Chinese-made Covid-19 vaccine – after obtaining approval from the country’s drug regulators. From there, they will be loaded into air-conditioned parts of cargo jets and fly to continents around the world.
The climate-controlled chambers at Shenzhen's international airport will soon be filled with Chinese-made coronavirus vaccines.
In the coming months, China will send hundreds of millions of doses of coronavirus vaccines to countries that have undergone end-stage testing. Chinese leaders have also promised a growing list of developing countries to have access to effective vaccines.
This global campaign gives China a chance to fix its image, which has been damaged by first-hand treatment of the coronavirus – rather than blaming the underlying spread of the undiagnosed virus for helping to eradicate the epidemic.
https://cloutnews.com/china-ready-to-dispatch-millions-of-covid-vaccine-doses-to-the-world/
Stock
2020-12-04 00:10 | Report Abuse
CHINA PREPS FOR COVID VACCINES ROLLOUTS
PRESSURE RISES BUT OFFICIALS STRESS STANDARDS
03 Dec 2020 ANALYSIS
China's Vice Premier Sun Chunlan and State Councilor Wang Yong have said preparations for rolling out the nation’s first coronavirus vaccines are underway, the remarks from the senior officials indicating the country could soon issues its first full and formal approvals.
The remarks came while the officials inspected production preparations in Beijing on 2 December, visiting the inspecting agency, the China Food and Drug Inspection Institute, and two leading vaccine makers - Sinovac Biotech Ltd. and state-owned Sinopharm Group Co. Ltd.’s China National Biotec Group (CNBG).
Both SinoVac and CNBG are developing inactivated virus-based candidates and the two frontrunners are among a total 14 vaccines under clinical study in China, five of which are in final Phase III studies.
The activity indicates that China is preparing for the full roll-out of the vaccines, despite no formal regulatory approvals being granted so far, industry insiders say. Both the SinoVac and CNBG vaccines already hold emergency use authorizations in China and are approved for use in the country's military.
One notable absentee from the official visit was CanSino Biologics Inc., whose adenovirus-based contender ad5-nCoV is also in Phase III development.
APPROVAL STANDARDS
“We should continue to scientifically and rigorously promote the Phase III clinical trials of vaccines, do a good job of review and approval in strict accordance with laws and regulations and internationally recognized technical standards, and ensure that vaccines are safe, effective and stand up to all aspects of testing," declared Sun during the visit, as quoted in local media.
China’s top health officials are assuring the public about the quality of domestically developed vaccines ahead of approval, which some suggest will be based on preliminary results from Phase III studies. Neither CNBG nor SinoVac have so far released their results from Phase III programs, which are all being conducted outside China in Indonesia, Turkey, Saudi Arabia, United Arab Emirates and Chile, as well as Argentina.
Conditional approval guidelines, issued by the National Medical Products Administration on 19 November, require only one or two Phase III results for vaccines deemed to be urgently needed for public health crises.
China has been touting its vaccines as a global “public good” and promised to supply them at affordable prices. But it may still need weeks before the formal approvals are granted, given uncertainty over mass manufacturing, who should get them first and preparations needed for its Centers for Disease Control (CDC).
Sun also pointed to ongoing preparations for large-scale production, quality oversight and compliance with regulations, procedures and requirements to ensure biosecurity and improvements to the whole traceability system, as well as the severe punishments for quality violations.
Other matters being worked on include distribution preparations which require cold chain logistics, the order for different categories of people to receive the vaccines, and personnel training for China CDC and grassroots health units.
REGULATORY PRESSURE MOUNTING
As the winter settles in with a potential worsening in infections, China plans to administer vaccinations to high-risk groups such as port workers dealing with imported goods. The infections currently officially reported by the government, numbering only in the dozens, are mostly returnees from overseas.
Since the UK yesterday became the first country to fully approve Pfizer Inc./BioNTech SE’s mRNA COVID-19 vaccine (Also see "UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine" - Scrip, 2 Dec, 2020.), China appears on track to green-light its domestically developed vaccines soon.
In Sun’s remarks, she emphasized the important role of vaccines and asked for more support, which indicates the mounting pressure for the formal approval of the nation’s first vaccine for the pandemic.
“Vaccines are related to the safety of people's lives, all relevant departments should strictly control the vaccine research and development, production, distribution and use, strengthen the capacity-building of approval and supervision, help research and development units and producing makers to solve practical problems,” she was quoted saying.
Meanwhile, a public campaign is also being planned in China to raise vaccines awareness and ensure inoculation once the first products do become available.
https://scrip.pharmaintelligence.informa.com/SC143419/China-Preps-For-First-COVID-Vaccine-Roll-Outs
Stock
2020-12-04 00:10 | Report Abuse
CHINA PREPS FOR COVID VACCINES ROLLOUTS
PRESSURE RISES BUT OFFICIALS STRESS STANDARDS
03 Dec 2020 ANALYSIS
China's Vice Premier Sun Chunlan and State Councilor Wang Yong have said preparations for rolling out the nation’s first coronavirus vaccines are underway, the remarks from the senior officials indicating the country could soon issues its first full and formal approvals.
The remarks came while the officials inspected production preparations in Beijing on 2 December, visiting the inspecting agency, the China Food and Drug Inspection Institute, and two leading vaccine makers - Sinovac Biotech Ltd. and state-owned Sinopharm Group Co. Ltd.’s China National Biotec Group (CNBG).
Both SinoVac and CNBG are developing inactivated virus-based candidates and the two frontrunners are among a total 14 vaccines under clinical study in China, five of which are in final Phase III studies.
The activity indicates that China is preparing for the full roll-out of the vaccines, despite no formal regulatory approvals being granted so far, industry insiders say. Both the SinoVac and CNBG vaccines already hold emergency use authorizations in China and are approved for use in the country's military.
One notable absentee from the official visit was CanSino Biologics Inc., whose adenovirus-based contender ad5-nCoV is also in Phase III development.
APPROVAL STANDARDS
“We should continue to scientifically and rigorously promote the Phase III clinical trials of vaccines, do a good job of review and approval in strict accordance with laws and regulations and internationally recognized technical standards, and ensure that vaccines are safe, effective and stand up to all aspects of testing," declared Sun during the visit, as quoted in local media.
China’s top health officials are assuring the public about the quality of domestically developed vaccines ahead of approval, which some suggest will be based on preliminary results from Phase III studies. Neither CNBG nor SinoVac have so far released their results from Phase III programs, which are all being conducted outside China in Indonesia, Turkey, Saudi Arabia, United Arab Emirates and Chile, as well as Argentina.
Conditional approval guidelines, issued by the National Medical Products Administration on 19 November, require only one or two Phase III results for vaccines deemed to be urgently needed for public health crises.
China has been touting its vaccines as a global “public good” and promised to supply them at affordable prices. But it may still need weeks before the formal approvals are granted, given uncertainty over mass manufacturing, who should get them first and preparations needed for its Centers for Disease Control (CDC).
Sun also pointed to ongoing preparations for large-scale production, quality oversight and compliance with regulations, procedures and requirements to ensure biosecurity and improvements to the whole traceability system, as well as the severe punishments for quality violations.
Other matters being worked on include distribution preparations which require cold chain logistics, the order for different categories of people to receive the vaccines, and personnel training for China CDC and grassroots health units.
REGULATORY PRESSURE MOUNTING
As the winter settles in with a potential worsening in infections, China plans to administer vaccinations to high-risk groups such as port workers dealing with imported goods. The infections currently officially reported by the government, numbering only in the dozens, are mostly returnees from overseas.
Since the UK yesterday became the first country to fully approve Pfizer Inc./BioNTech SE’s mRNA COVID-19 vaccine (Also see "UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine" - Scrip, 2 Dec, 2020.), China appears on track to green-light its domestically developed vaccines soon.
In Sun’s remarks, she emphasized the important role of vaccines and asked for more support, which indicates the mounting pressure for the formal approval of the nation’s first vaccine for the pandemic.
“Vaccines are related to the safety of people's lives, all relevant departments should strictly control the vaccine research and development, production, distribution and use, strengthen the capacity-building of approval and supervision, help research and development units and producing makers to solve practical problems,” she was quoted saying.
Meanwhile, a public campaign is also being planned in China to raise vaccines awareness and ensure inoculation once the first products do become available.
https://scrip.pharmaintelligence.informa.com/SC143419/China-Preps-For-First-COVID-Vaccine-Roll-Outs
Stock
2020-12-03 23:13 | Report Abuse
Turkey to use China's CoronaVac vaccine as early as December
https://www.trtworld.com/turkey/turkey-to-use-china-s-coronavac-vaccine-as-early-as-december-42030
Stock
2020-12-03 22:54 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:52 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:51 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:50 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:49 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:48 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:48 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:47 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:47 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:47 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:47 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:47 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:46 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:43 | Report Abuse
@UlarSawa Again that logic of who is funding WHO the most is frequently propagated by western media in order to attack WHO and China. The Western media are completely biased and making baseless accusations. Its all a political game nothing more as China is currently not at good terms with western countries. It is so obvious to see. I do not even need to explain this to you.
Stock
2020-12-03 22:39 | Report Abuse
@UlarSawa Whatever you read from western media needs to be taken with a pinch of salt as you know they are very biased, even towards islam religion they are very biased. Try to read wider and broaden your mind to understand the global situation and have a neutral view. China vaccines have no strings attached. The vaccines are meant to serve as a global public good presumably in order to redeem themselves from their error in handling the spread of covid from Wuhan in the first place. The government is striving to do everything in their power to ensure that the vaccines fully comply with international standards of safety, efficacy and quality and to ensure global access of covid vaccines regardless of socioeconomic status as their current reputation is at stake.
Stock
2020-12-03 22:30 | Report Abuse
@UlarSawa WHO is an independent international organisation. Of course they will be impartial. USA and European vaccines will be eligible for fast track approval from WHO as USFDA and EMA are stringent regulatory authorities whereas China's vaccine will be approved by WHO via normal route which may take slightly longer.
Stock
2020-12-03 22:27 | Report Abuse
Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets
https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826
Stock
2020-12-03 22:26 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:25 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:24 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:24 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:23 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:23 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:23 | Report Abuse
Market already priced in wont go much higher....
Stock
2020-12-03 22:20 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:19 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:00 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 22:00 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock
2020-12-03 21:59 | Report Abuse
Promise of Covid vaccines is ‘phenomenal’, WHO says
https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/
Stock: [KANGER]: KANGER INTERNATIONAL BERHAD
2020-12-04 15:06 | Report Abuse
Today will close at 0.175 lol no changes....